The largest database of trusted experimental protocols

7 protocols using cyto x cytoperm

1

Cytokine Profiling of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytokine secretion ability of B, T, and NK cells was detected using ow cytometry. Brie y, we diluted 100 µL of PBMCs with 400 µL of IMDM (Gibco-BRL, Grand Island, NY, USA) in polystyrene tubes, and then stimulated the cells with or without the leukocyte activation cocktail (BD GolgiPlug™, Germany) for 4 h at 37 ℃ in 5% CO 2 . After stimulation, uorochromeconjugated lineage antibodies (Supplementary Table 1) were added and incubated for 15 min at room temperature (RT) followed by lysis of the RBCs. The cells were then xed and permeabilized with 250 µL of Cyto x/Cytoperm (BD, Germany) at RT for 20 mins. After staining with uorochrome-conjugated cytokine antibodies (Supplementary Table 1) for 20 min at RT, the cell pellets were washed and resuspended in 200 µL PBS. The FACS Canto II ow cytometer (BD Biosciences) and the FACS DIVA software (BD Biosciences) were used for data acquisition and analysis, respectively. The gated lymphocyte populations were further assessed for intracellular cytokine-producing cells. The levels of intracellular cytokines after stimulation were quantitatively determined from the percentage of lymphocytes with higher uorescence intensity than cells without treatment.
+ Open protocol
+ Expand
2

Cytokine Profiling of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytokine secretion ability of B, T, and NK cells was detected using ow cytometry. Brie y, we diluted 100 µL of PBMCs with 400 µL of IMDM (Gibco-BRL, Grand Island, NY, USA) in polystyrene tubes, and then stimulated the cells with or without the leukocyte activation cocktail (BD GolgiPlug™, Germany) for 4 h at 37 ℃ in 5% CO 2 . After stimulation, uorochromeconjugated lineage antibodies (Supplementary Table 1) were added and incubated for 15 min at room temperature (RT) followed by lysis of the RBCs. The cells were then xed and permeabilized with 250 µL of Cyto x/Cytoperm (BD, Germany) at RT for 20 mins. After staining with uorochrome-conjugated cytokine antibodies (Supplementary Table 1) for 20 min at RT, the cell pellets were washed and resuspended in 200 µL PBS. The FACS Canto II ow cytometer (BD Biosciences) and the FACS DIVA software (BD Biosciences) were used for data acquisition and analysis, respectively. The gated lymphocyte populations were further assessed for intracellular cytokine-producing cells. The levels of intracellular cytokines after stimulation were quantitatively determined from the percentage of lymphocytes with higher uorescence intensity than cells without treatment.
+ Open protocol
+ Expand
3

Multiparameter Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six-parameter ow cytometric analysis was performed on whole blood, BM-, LN-and spleen-derived cells according to standard procedures using a panel of mAbs purchased from BD Biosciences (Pharmingen, San Diego, CA) as follows: anti-CD3-APC-Cy7 (clone SP34), anti-CD8-PE (clone RPA-T8), anti-Ki-67-PE-Cy7 (clone B56), anti-CD14-PE (clone M5E2), anti-CD16-FITC (clone 3G8), and anti-HLA-DR-APC (clone G46-6). The anti-CD4-PerCP-Cy5.5 (clone OKT4) was purchased from Biolegend (San Diego, CA, USA). Isotype antibody was used for a negative control of CD4, Ki67, HLA-DR, CD14 and CD16 expression. Intracellular staining for Ki-67 was performed at room temperature for 30 minutes following permeabilization with cyto x/cytoperm (BD Bioscience). Flow cytometric acquisition and analysis were performed on a BD Verse cytometer driven by the FACS Verse software (BD Biosciences). Analysis of the acquired data was performed using FlowJo software (TreeStar, Ashland, OR, USA) and graphs were prepared using Prism version 6.0 (GraphPad).
+ Open protocol
+ Expand
4

Cytokine Profiling of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytokine secretion ability of B, T, and NK cells was detected using ow cytometry. Brie y, we diluted 100 µL of PBMCs with 400 µL of IMDM (Gibco-BRL, Grand Island, NY, USA) in polystyrene tubes, and then stimulated the cells with or without the leukocyte activation cocktail (BD GolgiPlug™, Germany) for 4 h at 37 ℃ in 5% CO 2 . After stimulation, uorochromeconjugated lineage antibodies (Supplementary Table 1) were added and incubated for 15 min at room temperature (RT) followed by lysis of the RBCs. The cells were then xed and permeabilized with 250 µL of Cyto x/Cytoperm (BD, Germany) at RT for 20 mins. After staining with uorochrome-conjugated cytokine antibodies (Supplementary Table 1) for 20 min at RT, the cell pellets were washed and resuspended in 200 µL PBS. The FACS Canto II ow cytometer (BD Biosciences) and the FACS DIVA software (BD Biosciences) were used for data acquisition and analysis, respectively. The gated lymphocyte populations were further assessed for intracellular cytokine-producing cells. The levels of intracellular cytokines after stimulation were quantitatively determined from the percentage of lymphocytes with higher uorescence intensity than cells without treatment.
+ Open protocol
+ Expand
5

CD137 and NF-κB Profiling in GC

Check if the same lab product or an alternative is used in the 5 most similar protocols
For CD137 detection, the PBMCs or TILs of GC patients were placed in ow tubes, and 5 µL each of anti-CD45-PerCP antibody, anti-CD3-FITC antibody and anti-CD137-APC antibody was added. The cells were incubated in the dark for 10 min and washed with PBS once. Then, 200 µL of PBS was added for ow cytometry detection.
For examination of CD8 + T cells proliferation, CD8 + T cells of GC patients were placed in ow tubes. After washing with PBS once, 200 µL of PBS was added for ow cytometry detection.
For NF-κb detection, CD8 + T cells from GC patients treated with 10 µg/ml agonistic anti-CD137 mAb for 72h were placed in ow tubes. After washing with PBS once, Fixation/Permeabilization Solution (BD Cyto x/Cytoperm TM ) were added at room temperature for 30 min. After washing with PBS once, A NF-κB p65 rabbit mAb (1:1000, CST) was added. The cells were incubated in the dark for 1 h and washed with PBS once. Adding 5 µl anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 594 Conjugate) (1:500, CST) and incubating the cells in the dark for 30 min. After washing with PBS once, 200 µL of PBS was added for ow cytometry detection.
+ Open protocol
+ Expand
6

Evaluating CD137 and NF-κB in GC Immunology

Check if the same lab product or an alternative is used in the 5 most similar protocols
For CD137 detection, the PBMCs or TILs of GC patients were placed in ow tubes, and 5 µL each of an anti-CD45-PerCP antibody (BioLegend, USA), anti-CD3-FITC antibody (BioLegend, USA) and anti-CD137-APC antibody (BioLegend, USA) was added. The cells were incubated in the dark for 10 min and washed with PBS once. PBS (200 µL) was added for ow cytometry detection.
For examination of CD8 + T cells proliferation, CD8 + T cells of GC patients were placed in ow tubes and washed once with PBS. PBS (200 µL) was added for ow cytometry detection.
For NF-κB detection, CD8 + T cells from GC patients were treated with 10 µg/ml anti-CD137 mAb (BPS Bioscience, USA) for 72 h and placed in ow tubes. After washing once with PBS, a Fixation/Permeabilization Solution (BD Cyto x/Cytoperm TM ) was added at room temperature for 30 min. After washing once with PBS, an NF-κB p65 rabbit mAb (1:1000, CST, USA) was added. The cells were incubated in the dark for 1 h and washed once with PBS. Five microliters of anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 594 Conjugate) (1:500, CST, USA) was added, and the cells were incubated in the dark for 30 min. After washing once with PBS, 200 µL of PBS was added for ow cytometry detection.
+ Open protocol
+ Expand
7

Evaluating CD137 and NF-κB in GC Immunology

Check if the same lab product or an alternative is used in the 5 most similar protocols
For CD137 detection, the PBMCs or TILs of GC patients were placed in ow tubes, and 5 µL each of an anti-CD45-PerCP antibody (BioLegend, USA), anti-CD3-FITC antibody (BioLegend, USA) and anti-CD137-APC antibody (BioLegend, USA) was added. The cells were incubated in the dark for 10 min and washed with PBS once. PBS (200 µL) was added for ow cytometry detection.
For examination of CD8 + T cells proliferation, CD8 + T cells of GC patients were placed in ow tubes and washed once with PBS. PBS (200 µL) was added for ow cytometry detection.
For NF-κB detection, CD8 + T cells from GC patients were treated with 10 µg/ml anti-CD137 mAb (BPS Bioscience, USA) for 72 h and placed in ow tubes. After washing once with PBS, a Fixation/Permeabilization Solution (BD Cyto x/Cytoperm TM ) was added at room temperature for 30 min. After washing once with PBS, an NF-κB p65 rabbit mAb (1:1000, CST, USA) was added. The cells were incubated in the dark for 1 h and washed once with PBS. Five microliters of anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 594 Conjugate) (1:500, CST, USA) was added, and the cells were incubated in the dark for 30 min. After washing once with PBS, 200 µL of PBS was added for ow cytometry detection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!